Clinical Trials Week
Susan Hasty, Publisher
Table of Contents . . . October 13th, 2008
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Clinical Trials Week | Other Publications
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College - HIV drug maraviroc effective for drug-resistant patients
Sciele Pharma, Inc. - Sciele Pharma Announces That Plethora Solutions Has Completed European Phase III Trial of PSD502 for Premature Ejaculation
Cancer - Research from Royal Marsden Hospital yields new findings on cancer
Cancer Vaccines - Reports from Stanford University describe recent advances in cancer vaccines
Carcinoma - New research on carcinoma from T. Andre and co-authors summarized
Chemotherapy - New findings from L.J. Swinnen and co-authors describe advances in chemotherapy
Enzyme Research - Data on enzyme research published by researchers at University of Florence
Gastric Cancer - Reports from Odense University highlight recent research in gastric cancer
HIV/AIDS - New HIV/AIDS findings from S. Mehendale and co-researchers published
Life Sciences - Recent studies by R. Mehrotra and co-authors add new data to life sciences findings
Measles - Research from Mayo Clinic provides new data on measles
Non-Small Cell Lung Cancer - Report summarizes non-small cell lung cancer study findings from H. Kunitoh and co-researchers
Pancreatic Cancer - Researchers at University of Heidelberg publish new data on pancreatic cancer
Prostate Cancer - Research from M.K. Chadha and co-researchers provides new data on prostate cancer
Prostate Cancer - Research from University of Michigan in the area of prostate cancer described
Breast Cancer Therapy - City Hospital reports research in breast cancer therapy
Breast Cancer Therapy - Findings from Virginia Commonwealth University, Department of Radiation Oncology advance knowledge in breast cancer therapy
Cancer Therapy - Data on cancer therapy published by researchers at Northwestern University
Carcinoma Therapy - New carcinoma therapy findings from Institute of Oncology, Department of Radiation Oncology described
Chemotherapy - Research from Hospital de Pediatria provide new insights into chemotherapy in children
Chemotherapy - Research on chemotherapy in children discussed by scientists at Hospital de Pediatria
Clinical Trial Research - Researchers at Chinese Academy of Sciences target clinical trial research
HIV/AIDS Vaccines - Research reports from Fred Hutchinson Cancer Research Center provide new insights into HIV/AIDS vaccines
Melanoma Therapy - University of Schleswig-Holstein, Department of Dermatology details research in melanoma therapy
Prostate Cancer Therapy - New findings from Mount Vernon Hospital in the area of prostate cancer therapy published
A.P. Pharma, Inc. - A.P. Pharma Announces Positive Phase 3 Results with APF530 in the Prevention of CINV
Advinus Therapeutics P Ltd. - Advinus Therapeutics P Ltd. and Ortho-McNeil-Janssen Pharmaceuticals, Inc. Establish Drug Discovery and Development Collaboration
Aeolus Pharmaceuticals, Inc. - Aeolus Pharmaceuticals Announces Initiation of Multiple Dose Study of AEOL 10150 in a Patient with ALS
Allergies - Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology
APT Pharmaceuticals, Inc. - APT Pharmaceuticals Secures $32 Million in Series B Financing
Apthera, Inc. - Apthera Announces Optimal Dose and Schedule of NeuVax for Phase III Clinical Trial in Breast Cancer
Aptuit Inc. - Aptuit Launches Program to Accelerate Early Stage Drug Development
ArQule, Inc. - ArQule Achieves Clinical Milestone in MiT Trial with ARQ 197
Bronchiectasis - ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia
Cempra Pharmaceuticals, Inc. - Cempra Pharmaceuticals and Biovista Enter Agreement for Macrolide Clinical Trial Design Support Studies
Clinical Trial Research - Critical Pharmaceuticals Enter Sustained Release hGH Arena
Clinical Trial Research - Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
Columbia Laboratories, Inc. - Columbia Laboratories Reports Results from Phase II Clinical Trial of Vaginally-administered Lidocaine for Dysmenorrhea
Companies and Markets - Companies and Markets: "Innovative Clinical Trial Design and Management - Trends, success stories and impact upon research and development budgets" market report available now
Cystic Fibrosis - Transave, Inc. Secures $12.5 Million in New Financing
Drug Development - NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting
Emergent BioSolutions Inc. - Emergent BioSolutions Signs Contract with BARDA/NIAID, Valued at Up to $29.7 Million, to Fund Development of AV7909 - a Next Generation Anthrax Vaccine
Genentech, Inc. - Genentech, GlycArt and Roche Enter into Collaboration Agreement for Potential Cancer Therapy
Haemacure Corporation - Haemacure Appoints Thomas J. Lynch, J.D., Ph.D. to Board of Directors
Headache and Migraine - TorreyPines Therapeutics Reports Successful End-of-Phase II Meeting With FDA for Tezampanel
Hollis-Eden Pharmaceuticals, Inc. - Hollis-Eden Pharmaceuticals Presents Additional Positive Findings for APOPTONE HE3235 in Preclinical Models of Castration-Resistant Prostate Cancer
Idera Pharmaceuticals, Inc. - Idera Pharmaceuticals Announces Preliminary Data from Phase 2a Clinical Study of IMO-2055 Monotherapy in Renal Cell Carcinoma
Neuropathic Pain - Pharmaleads' Lead Candidate for Pain, PL37, Enters Phase I
NewsRx - NewsRx Launches 19 New Technology Titles
OncoGenex Pharmaceuticals, Inc. - OncoGenex To Present At the BioContact Quebec 2008 Annual Conference
Ore Pharmaceuticals Inc. - Ore Pharmaceuticals Begins Clinical Trial of GL1001
PPD, Inc. - PPD Completes Acquisition of InnoPharm
Progenics Pharmaceuticals, Inc. - Progenics Announces Progress and Presentations in HIV Therapy Program
pSivida Corp. - pSivida Release: Results from the Six-Month Interim Readout of the Human PK Iluvien Study
Psoriasis - Synvista Therapeutics Receives Approval to Begin Phase 2 Trial of Topical SYI-2074 in Psoriasis
Telormedix SA - Telormedix Raises 21 Mio CHF in Series a Financing
Tranzyme Pharma - Tranzyme Pharma Announces Positive Phase IIb Results with Its Ghrelin Agonist, TZP-101, for Postoperative Ileus POI
VGX Pharmaceuticals - VGX Pharmaceuticals Awarded $23.5 Million NIH Contract to Develop DNA-Based Preventive HIV Vaccine Delivered Via Electroporation
VGX Pharmaceuticals - VGX Pharmaceuticals Commences Follow-on Phase I Study for Novel Oral Anti-Inflammatory Drug Targeting Rheumatoid Arthritis and Type 1 Diabetes
ViroStatics, srl - Virostatics' President and CEO, Dr. Franco Lori, to address the 2nd World Conference on Magic Bullets Ehrlich II in Nurnberg, Germany
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
